TRX818

• Catalog number
  B1223-5
• Price
  Please ask
• Size
  5 mg

• Alternative_name
  Sodium (2-(3-fluorophenyl)-6-methoxy-4-oxo-1,4-dihydroquinolin-5-yl)phosphonate
• Description
  TRX818 is an orally bioavailable agent with potential antineoplastic and anti-vasculogenic mimicry (VM) activities. TRX-818, upon oral administration appears to induce cancer cell apoptosis and inhibits cancer cell proliferation. TRX818 also prevents tumor cell VM by blocking the formation of vasculogenic-like tubular structures.
• CAS Number
  1256037-58-7
• Structure Available
  Yes
• Salt Form
  No
• Molecular Formula
  C₁₆H₁₁FNNaO₅P
• Molecular Weight
  393.21
• Cell Permeable
  Yes
• Purity
  ≥98% by HPLC
• Solubilities
  DMSO
• Handling
  Protect from air and light
• Tag Line
  An orally bioavailable agent with potential antineoplastic and anti-vasculogenic mimicry (VM) activities
• Storage Condition
  -20°C
• Shipping Condition
  gel pack
• Shelf Life
  36 months
• SMILES
  O=C1C=C(C2=CC=CC(F)=C2)NC3=C1C(P([O-])([O-])=O)=C(OC)C=C3.[Na+].[Na+]
• InChi
  InChI=1S/C16H13FNO5P.2Na/c1-23-14-6-5-11-15(16(14)24(20,21)22)13(19)8-12(18-11)9-3-2-4-10(17)7-9;;/h2-8H,1H3,(H,18,19)(H2,20,21,22);;/q;2*+1/p-2
• InChi Key
  ZRPWVAHVWBPHID-UHFFFAOYSA-L
• Data Sheet Link
• MSDS Available
  Yes

• Gene target
  TRX818  
• Short name
  TRX818
• Alternative name
  TRX818

Similar products